Previous 10 | Next 10 |
SUWANEE, GA, April 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, received United S...
SANUWAVE Health, Inc (SNWV) Q4 2018 Results Earnings Conference Call March 29, 2019, 10:00 AM ET Company Participants Lisa Sundstrom - CFO Kevin Richardson - Chairman and Chief Executive Officer Pete Stegagno - COO Iulian Cioanta - Chief Science Officer Shri Parikh - Preside...
SANUWAVE Health ( OTCQB:SNWV ): FY GAAP EPS of -$0.08 beats by $0.01 . More news on: SANUWAVE Health, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SUWANEE, Ga., March 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) will report financial results for the year ended December 31, 2018 with the SEC on Monday, April 1, 2019. The Company will also host a conference call today, March 29, 2019 at 10...
SUWANEE, GA, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Friday, March 29, 2019, beginning at 10AM Eastern Time to discuss the 2018 financial results, provide a business upd...
SUWANEE, GA, March 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, anno...
SUWANEE, GA, March 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) , an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, is excit...
SUWANEE, GA, March 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) , an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, is excited...
CORAL SPRINGS, FL / ACCESSWIRE / March 5, 2019 / As investors, from time to time, we see a ticker that has risen dramatically over the years and think, "I wish I would have found that one a while back." These companies come up with blockbuster products, often turning thousandaires into milli...
PHOENIX, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed SANUWAVE Health, Inc. (SNWV) (“the Company), a shock wave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating device...
News, Short Squeeze, Breakout and More Instantly...
SANUWAVE is pleased to announce preliminary revenues of $7.0 million to $7.2 million for the second quarter ended June 30, 2024. This represents the highest quarterly revenues in company history. Q1 2024 revenue increased between 50% and 54% compared to Q2 2023. UltraMist revenues for Q2 2024...
Company to Pursue Alternate Plans for Capital Structure Improvement Including a Proposed Reverse Stock Split and a Note and Warrant Exchange Independent of a Merger Transaction EDEN PRAIRIE, MN - ( NewMediaWire ) - June 26, 2024 - SANUWAVE Health, Inc. (the “Company”...
SANUWAVE pays off $6.3 million Celularity note and interest for $2.075 million SEPA merger outside date to be extended to June 30, 2024 Combined entity has applied to list on Cboe BZX Exchange, Inc. EDEN PRAIRIE, MN - ( NewMediaWire ) - June 04, 2024 - SANUWAVE...